Poultry farmers in Zimbabwe are allegedly feeding antiretroviral medicines to chickens to accelerate growth and survive disease, sparking severe warnings from health and scientific authorities about antimicrobial resistance and chemical-induced meat contamination. According to Dr. Linda Bester of the Animal Research Ethics Committee at the University of KwaZulu-Natal, who spoke to 702’s Bongani Bingwa, the practice is a completely false myth that creates dangerous, drug-resistant germs.
Why Farmers Are Illegally Using HIV Pills in Poultry Feed
Some agricultural operators believe that human HIV medications help broiler chickens put on weight faster and withstand common poultry ailments. However, Dr. Linda Bester explained in her interview with 702’s Bongani Bingwa that the practice is completely illegal and involves drugs acquired through the black market. Rather than generating actual muscle mass, the human medications cause watery chemical bloating, giving the false illusion that the birds are larger and growing at an accelerated rate.
Commercial broiler chickens are already bred to reach market size rapidly. Farmers frequently slaughter the birds earlier in their life cycles, before specific poultry diseases have time to develop, which inadvertently creates the misleading impression that human ARVs improve survival rates.
Did you know?
Unlike regulated veterinary treatments, human medicines lack approved withdrawal periods and safety testing protocols for animals bred for human consumption, presenting hidden risks to the food supply chain.
Public Health Risks and Antimicrobial Resistance Concerns
The diversion of life-saving human medicines into agricultural commodities poses severe risks to human health. According to Dr. Linda Bester, consuming small amounts of drug residues over extended periods contributes directly to drug-resistant strains of pathogens. When patients genuinely require these specific treatments for HIV, the medications may fail to work.
This misuse aligns with the broader global challenge of antimicrobial resistance, which the World Health Organisation categorizes as a silent pandemic. Under these conditions, the strongest germs survive and multiply, eventually rendering essential modern medicines ineffective for both animals and humans.
Frequently Asked Questions
Do antiretroviral medicines actually make chickens grow faster?
No. According to Dr. Linda Bester, the belief is a complete myth. The medications only cause watery chemical bloating, making the birds appear larger without adding genuine muscle mass.
Where are farmers obtaining these human medications?
Experts indicate that these life-saving human drugs are being illegally acquired through the black market.
Is it legal to use human medicine in farm animals?
No. Human medications are never approved for use in animals bred for human consumption and lack the strict withdrawal periods and regulatory safety testing required for veterinary products.
Join the Conversation
What are your thoughts on strengthening regulations surrounding the supply chain of human medications to prevent agricultural misuse? Leave a comment below, share this report with your network, or subscribe to our newsletter for the latest updates on food safety and public health.
Related reading
- Trump’s Threat to Crush Iran’s Oil Like Venezuela
- Poland Scrambles Jets After Russian Drone Hits Train Near Border
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)